Package 55910-695-50

Brand: dollar general headache powders

Generic: aspirin and caffeine
NDC Package

Package Facts

Identity

Package NDC 55910-695-50
Digits Only 5591069550
Product NDC 55910-695
Description

24 PACKET in 1 CARTON (55910-695-50) / 1 POWDER in 1 PACKET

Marketing

Marketing Status
Marketed Since 2021-03-31
Brand dollar general headache powders
Generic aspirin and caffeine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "89e6945c-1b9d-4def-889e-a37f33ca8c48", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0023513113104"], "unii": ["R16CO5Y76E", "3G6A5W338E"], "rxcui": ["994435"], "spl_set_id": ["11b0271b-d65c-49c4-a081-d71044a0e04c"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Dolgencorp, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "18 PACKET in 1 CARTON (55910-695-18)  / 1 POWDER in 1 PACKET", "package_ndc": "55910-695-18", "marketing_start_date": "20210331"}, {"sample": false, "description": "24 PACKET in 1 CARTON (55910-695-50)  / 1 POWDER in 1 PACKET", "package_ndc": "55910-695-50", "marketing_start_date": "20210331"}], "brand_name": "Dollar General Headache Powders", "product_id": "55910-695_89e6945c-1b9d-4def-889e-a37f33ca8c48", "dosage_form": "POWDER", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "55910-695", "generic_name": "Aspirin and Caffeine", "labeler_name": "Dolgencorp, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Dollar General Headache Powders", "active_ingredients": [{"name": "ASPIRIN", "strength": "845 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210331", "listing_expiration_date": "20261231"}